Likewise, linc-regulator of reprogramming has been demonstrated to trigger the transition of ER+ BC cells from an estrogen-dependent to an estrogen-independent state, a key step in promoting endocrine therapy resistance [23]. This evidence concerns the gene ESR1 and breast cancer.